Cardizem Tablet, Coated
NDC Package 0187-0771-47
Package Information
Cardizem (diltiazem hydrochloride) tablets is diltiazem is used to prevent chest pain (angina). This formulation utilizes a tablet, coated delivery system. Marketed by Bausch Health Us Llc, this product is identified by NDC 0187-0771 and is authorized under FDA application NDA018602.
Identification & Billing
- RxCUI: 831054 - dilTIAZem hydrochloride 120 MG Oral Tablet
- RxCUI: 831054 - diltiazem hydrochloride 120 MG Oral Tablet
- RxCUI: 831055 - Cardizem 120 MG Oral Tablet
- RxCUI: 831055 - diltiazem hydrochloride 120 MG Oral Tablet [Cardizem]
- RxCUI: 831102 - dilTIAZem HCl 90 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0187 - Bausch Health Us Llc
- 0187-0771 - Cardizem
- 0187-0771-47 - 100 TABLET, COATED in 1 BOTTLE
- 0187-0771 - Cardizem
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0187-0771). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0187-0771-47 identifies a specific commercial package of 100 tablet, coated in 1 bottle of Cardizem, a human prescription drug labeled by Bausch Health Us Llc. This tablet, coated is formulated for oral use and contains diltiazem hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch Health Us Llc on December 25, 2010. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Diltiazem is used to prevent chest pain (angina). It may help to increase your ability to exercise and decrease how often you may get angina attacks. Diltiazem is called a calcium channel blocker. It works by relaxing blood vessels in the body and heart and lowers the heart rate. Blood can flow more easily and your heart works less hard to pump blood.
How is this Bausch Health Us Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00187077147. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.